Launch week offerEnds in00h00m00s

annual Promonthly Pro

Wayne Dimech

University of Melbourne

Australia

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Australia Professors in Immunology Immunology professors in Australia

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Collaborators (13)

Mario Plebani

University of Padova

ITALY

View details

Krispin Hajkowicz

Associate Professor

University of Queensland

AUSTRALIA

View details

Anna Wilkinson

Senior Research Fellow

Burnet Institute

AUSTRALIA

View details

Basil Donovan

Emeritus Professor

University of New South Wales

AUSTRALIA

View details

Mark DS Shephard

Flinders University

AUSTRALIA

View details

James O'Beirne

University of the Sunshine Coast

AUSTRALIA

View details

Susan Matthews

Flinders University

AUSTRALIA

View details

Marc Thelen

Professor by special appointment 'quality in medical laboratory care'

Radboud University Medical Center

NETHERLANDS

View details

Janaki Amin

University of New South Wales

AUSTRALIA

View details

Golo Ahlenstiel

Professor of Medicine

University of Western Sydney

AUSTRALIA

View details

Alisa Pedrana

Principal Research Fellow

Burnet Institute

AUSTRALIA

View details

Emmanuel J Favaloro

Charles Sturt University - Wagga Wagga Campus

AUSTRALIA

View details

Etienne Cavalier

Full Professor

University of Liege

BELGIUM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Wayne Dimech

Research Interests

Make your next move.

Explore related searches

Articles (20)

Harmonization of measurement units: mission impossible or ethical imperative?

Reflex Testing for Hepatitis D Infection: A Unique Opportunity to Reduce Hepatitis D‐Related Chronic Liver Disease Deaths in Australia

Correction: A qualitative evaluation of access to essential laboratory services for communicable diseases at the primary health care level in the Western Pacific Region (Tropical Medicine and Health, (2025), 53, 1, (156), 10.1186/s41182-025-00797-3)

The Hepatitis C Cascade of Care for Opioid Agonist Therapy Recipients in Australia

Understanding quality control processes for infectious disease testing

A qualitative evaluation of access to essential laboratory services for communicable diseases at the primary health care level in the Western Pacific Region

Questioning the proper comparison of QConnect limits to quality control: authors' reply to Westgard et al.

Cost-benefit analysis of two quality control approaches for infectious disease testing

Hepatitis B susceptibility and subsequent vaccination in priority populations across an Australian sentinel surveillance network, 2017-2023

Evidence-based assessment of the application of Six Sigma to infectious disease serology quality control

Point-of-care testing: state-of-the art and perspectives

Rubella Serology: A Renewed Call to Action

Quality control and external quality assessment for the independent clinic-based evaluation of point-of-care testing to detect Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis in eight countries.

Chlamydia retesting remains low among young women in Australia

Risk of Primary Incident Hepatitis C Infection Following Bacterial Sexually Transmissible Infections Among Gay and Bisexual Men in Australia From 2016 to 2020

External quality control processes for infectious disease testing

Comprehensive, comparative evaluation of 25 automated SARSCoV-2 serology assays

Response to Tony Badrick regarding “Letter to the Editor regarding the article by Wayne J. Dimech et al. Time to address quality control processes applied to antibody testing for infectious diseases. Clin Chem Lab Med 2023; 61(2):205–212 by”

A-245 Reagent Lot Variation—When should I be Concerned?

A-361 Implementation of a Fit-for-purpose Point of Care Quality Assurance Program

Collaborators (13)

Mario Plebani

Krispin Hajkowicz

Anna Wilkinson

Basil Donovan

Mark DS Shephard

James O'Beirne

Susan Matthews

Marc Thelen

Janaki Amin

Golo Ahlenstiel

Alisa Pedrana

Emmanuel J Favaloro

Etienne Cavalier

Make your next move.